| 000 | 01775 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513200609.0 | ||
| 264 | 0 | _c20000217 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a0014-2999 | ||
| 024 | 7 |
_a10.1016/s0014-2999(99)00715-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPihlavisto, M | |
| 245 | 0 | 0 |
_aFunctional assessment of recombinant human alpha(2)-adrenoceptor subtypes with cytosensor microphysiometry. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmacology _cDec 1999 |
||
| 300 |
_a247-53 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic alpha-Agonists _xmetabolism |
| 650 | 0 | 4 |
_aAmiloride _xanalogs & derivatives |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBinding, Competitive _xdrug effects |
| 650 | 0 | 4 | _aBiosensing Techniques |
| 650 | 0 | 4 | _aBrimonidine Tartrate |
| 650 | 0 | 4 | _aCHO Cells |
| 650 | 0 | 4 |
_aCholera Toxin _xpharmacology |
| 650 | 0 | 4 |
_aClonidine _xmetabolism |
| 650 | 0 | 4 | _aCricetinae |
| 650 | 0 | 4 |
_aDexmedetomidine _xmetabolism |
| 650 | 0 | 4 |
_aEgtazic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrogen-Ion Concentration |
| 650 | 0 | 4 |
_aNorepinephrine _xmetabolism |
| 650 | 0 | 4 | _aPertussis Toxin |
| 650 | 0 | 4 |
_aQuinoxalines _xmetabolism |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-2 _xgenetics |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 |
_aVirulence Factors, Bordetella _xpharmacology |
| 700 | 1 | _aScheinin, M | |
| 773 | 0 |
_tEuropean journal of pharmacology _gvol. 385 _gno. 2-3 _gp. 247-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-2999(99)00715-3 _zAvailable from publisher's website |
| 999 |
_c10563860 _d10563860 |
||